Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1990-04-26
1993-03-09
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
514423, A61K 4300, A61K 3140
Patent
active
051925249
ABSTRACT:
A method of inhibiting carcinogenesis following radiation therapy includes the steps of irradiating a tissue with x-ray or gamma radiation, administering Captopril after irradiation, reducing the severity of radiation induced normal tissue injury, and decreasing the risk of a secondary malignancy in the irradiated tissue.
REFERENCES:
CA 109(15): 125079h, Ward et al., Int. J. Radiat. Oncol. Biol. Phys., 15(1), pp. 135-140 (1988).
Hinz Joann M.
Molteni Agostino
Ts'ao Chung-hsin
Ward William F.
Covert John M.
Lovering Richard D.
Northwestern University
LandOfFree
Captopril as a cancer chemopreventive agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Captopril as a cancer chemopreventive agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Captopril as a cancer chemopreventive agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-209479